Alberta Investment Management Corp bought a new stake in Avantor, Inc. (NYSE:AVTR – Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 1,111,144 shares of the company’s stock, valued at approximately $12,734,000.
A number of other hedge funds also recently added to or reduced their stakes in AVTR. EverSource Wealth Advisors LLC lifted its stake in Avantor by 119.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after buying an additional 1,189 shares during the last quarter. Private Trust Co. NA lifted its stake in Avantor by 46.2% in the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after buying an additional 875 shares during the last quarter. Strategic Wealth Investment Group LLC bought a new stake in Avantor in the second quarter valued at $32,000. Los Angeles Capital Management LLC bought a new stake in Avantor in the fourth quarter valued at $32,000. Finally, Osaic Holdings Inc. raised its stake in shares of Avantor by 60.9% during the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after purchasing an additional 1,064 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
AVTR has been the topic of a number of recent analyst reports. Royal Bank Of Canada initiated coverage on shares of Avantor in a research note on Thursday, May 14th. They set a “sector perform” rating and a $9.00 price objective on the stock. Zacks Research upgraded shares of Avantor from a “strong sell” rating to a “hold” rating in a research note on Thursday, April 30th. Wall Street Zen cut shares of Avantor from a “buy” rating to a “hold” rating in a research note on Saturday, May 30th. Wolfe Research cut shares of Avantor to an “underperform” rating and set a $7.00 price objective on the stock. in a research note on Monday, June 1st. Finally, Barclays cut their price objective on shares of Avantor from $8.50 to $7.00 and set an “underweight” rating on the stock in a research note on Tuesday, April 14th. Two investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Reduce” and a consensus target price of $10.57.
Insider Transactions at Avantor
In other news, Director Gregory T. Lucier bought 10,000 shares of the stock in a transaction that occurred on Friday, May 8th. The shares were purchased at an average cost of $8.32 per share, with a total value of $83,200.00. Following the completion of the acquisition, the director directly owned 60,000 shares in the company, valued at approximately $499,200. The trade was a 20.00% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Simon Dingemans bought 25,000 shares of the stock in a transaction that occurred on Friday, May 1st. The shares were purchased at an average cost of $8.14 per share, for a total transaction of $203,500.00. Following the completion of the acquisition, the director owned 25,000 shares of the company’s stock, valued at $203,500. This trade represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.28% of the stock is owned by insiders.
Avantor Price Performance
Shares of NYSE AVTR opened at $9.71 on Tuesday. Avantor, Inc. has a fifty-two week low of $7.26 and a fifty-two week high of $15.93. The firm’s 50-day simple moving average is $8.41 and its 200 day simple moving average is $9.60. The company has a quick ratio of 1.17, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market cap of $6.63 billion, a P/E ratio of -11.99, a P/E/G ratio of 5.45 and a beta of 0.97.
Avantor (NYSE:AVTR – Get Free Report) last released its earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.54 billion. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.Avantor’s revenue was up .0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.23 earnings per share. Equities analysts expect that Avantor, Inc. will post 0.79 EPS for the current year.
Avantor Profile
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
See Also
- Five stocks we like better than Avantor
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
